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ABSTRACT
The Hospital Universitari de Bellvitge (Barcelona, Spain) records all cases of bacterial meningitis in a
120-variable database. The characteristics of bacterial meningitis in cirrhotic patients are not well-
known, and all cases of community-acquired bacterial meningitis occurring in cirrhotic patients were
therefore identified. During 1977–2002, there were 602 episodes of community-acquired bacterial
meningitis in adults, of which 29 (4.8%) occurred in cirrhotic patients. Compared to non-cirrhotic
patients, there were significant differences in: duration of disease for >4 days at the time of diagnosis;
absence of nuchal rigidity; certain aetiologies, e.g., Escherichia coli and Listeria monocytogenes; renal and
liver function impairment; relapse of fever; and incidence of relapse and mortality. Overall, bacterial
meningitis in cirrhotic patients was associated with a high mortality rate and a large number of
complications. A high index of suspicion is necessary because of the frequent absence of meningeal
signs. In addition to the classic meningeal pathogens, other aetiologies, including E. coli and
L. monocytogenes, should be considered when prescribing empirical therapy.
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INTRODUCTION
Cirrhotic patients present with a higher frequency
of bacterial infections than do non-cirrhotic
patients, and this has been attributed to mecha-
nisms that include a deficient immune response,
bacterial translocation, and hepatic reticulo-endo-
thelial system deficiencies. [1–4]. Bacterial infec-
tions are considered to be a major complication
and an important cause of death in patients with
liver cirrhosis [5]. However, bacterial meningitis
is not thought to occur at a high frequency among
cirrhotic patients; previous studies concerning
meningitis in cirrhotic patients are consequently
scarce and the characteristics of this syndrome are
not well-known. Only a few published series have
previously described bacterial meningitis in
patients with liver cirrhosis, and these studies
have reported special complications and difficult
outcomes [6–9]. Cirrhosis does not appear as
an important underlying disease in general
meningitis series [10–13], but because severe
sepsis is frequent in cirrhotic patients, complicat-
ing meningitis is a possibility, and atypical clin-
ical characteristics may lead to a delay in
diagnosis in the absence of a high degree of
suspicion. Accordingly, the aim of the present
study was to provide further information con-
cerning the aetiology and clinical characteristics
of bacterial meningitis in adult patients with liver
cirrhosis.
PATIENTS AND METHODS
Setting
The Hospital Universitari de Bellvitge is a 1000-bed teaching
hospital for adult patients in Barcelona, Spain. Since 1977, all
cases of bacterial meningitis have been recorded routinely in a
120-variable computerised database. For the purpose of the
present study, all cases of community-acquired bacterial
meningitis occurring in patients with liver cirrhosis were
identified and analysed.
Clinical and microbiological studies
An initial lumbar puncture and two blood cultures were
performed routinely in all cases of suspected bacterial men-
ingitis. Cerebrospinal fluid (CSF) samples were submitted for
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Gram’s stain, bacterial culture and cytochemical determina-
tions, including white blood cell counts and determination of
protein and glucose concentrations. After centrifugation of
CSF specimens, the resulting sediment was used to prepare
smears for microscopical examination and to inoculate blood
and chocolate agar plates and thioglycolate broth. Micro-
biological identification was performed according to stan-
dard methods [14]. Antibiotic susceptibilities were deter-
mined by disk-diffusion, complemented, if necessary, by
determination of MICs and minimum bactericidal concentra-
tions [15]. All patients were evaluated daily and underwent
a complete panel of haematological and biochemical tests,
including liver and renal function tests, within 48 h of
admission, and then at least once-weekly during hospitali-
sation, and once more within the next 4 weeks at the
outpatient clinic.
Definitions
Bacterial meningitis was diagnosed in patients with clinical
findings suggestive of meningitis and a positive CSF culture,
or clinical findings and CSF polymorphonuclear pleocytosis
(white blood cell count >100 ⁄mm3, 90% neutrophils). When a
Gram’s stain and blood cultures of CSF samples were negative,
meningitis of unknown origin was recorded, although a
meningococcal aetiology was recorded when characteristic
skin lesions were present. Hepatic cirrhosis was diagnosed
either by histological or clinical–biological criteria (jaundice,
ascitic decompensation, hepatic encephalopathy and variceal
bleeding) and ultrasonographic and endoscopic findings.
Relapse was defined as the renewed presentation of symptoms
of meningitis, associated with the same microorganism, after
an initial improvement following antibiotic therapy. Mortality
during hospitalisation was recorded. Impairment of hepatic
function was defined as a doubling in alanine aminotransfer-
ase ⁄ aspartate aminotransferase levels and ⁄or serum alkaline
phosphatase levels. Impairment of renal function was defined
as a doubling in the serum creatinine level or a level of
>150 lmol ⁄L.
Antibiotic therapy
Antibiotic use has changed over the years according to
changes in resistance patterns. Penicillin or chloramphenicol
was used until 1984, with a third-generation cephalo-
sporin ± ampicillin being used subsequently. Therapy for
pneumococcal meningitis consisted of vancomycin during
1988–1989 as part of a clinical trial [16], with high-dose
cefotaxime ± vancomycin being used after 1990 until antibiotic
susceptibilities were known. All patients in this hospital with
suspected pneumococcal meningitis have been treated rou-
tinely since 1987 with dexamethasone (4 mg ⁄ 6 h for 48 h, for
eight doses) beginning 10–15 min before antibiotic therapy,
with a doubled first dose.
Statistical analysis
Continuous variables were expressed as either the mean
(standard deviation) or the median (inter-quartile range),
depending on the Kolmogorov–Smirnov normality test. Uni-
variate analysis of variables from the entire patient population
was performed using chi-squared tests and two-sample t-tests,
or the Mann–Whitney U-test for continuous data. Multivariate
conditional logistic regression for datasets was used to identify
independent associations with a cirrhotic status, with results
presented as OR (95% CI).
RESULTS
Between 1977 and 2002, 602 episodes of commu-
nity-acquired bacterial meningitis were recorded
in patients aged >18 years. Of these, 229 were
caused by Neisseria meningtidis (44 were culture-
negative, but were diagnosed as meningococcal
meningitis on the basis of characteristic skin
lesions), 186 were caused by Streptococcus pneu-
moniae, 33 were caused by Listeria monocytogenes,
72 were considered to be of unknown aetiology,
and the remainder had other aetiologies. Of the
602 episodes, 29 occurred in cirrhotic patients, 13
of whom had a histological diagnosis. Tables 1
and 2 show the clinical and laboratory character-
istics and the outcome of these patients. There
were 13 males and the mean age was
55.8 ± 2 years. Thirteen patients presented with
at least one underlying condition: diabetes mell-
itus (n = 9), diabetes mellitus and splenectomy
(n = 1), splenectomy (n = 1), neoplasm (n = 1),
chronic steroidal therapy (n = 1) and chronic
renal failure (n = 1). Ten patients belonged to
group A of the Child–Pugh classification, seven to
group B and ten to group C. The Child–Pugh
classification could not be established for two
patients with S. pneumoniae meningitis who died
rapidly. Liver disease was alcohol related in
Table 1. Comparison of episodes of meningitis in non-
cirrhotic and cirrhotic patientsa
Non-cirrhotic
(n = 573) Cirrhotic (n = 29)
n ⁄ total % n ⁄ total % p
Length of disease >4 days 92 ⁄ 566 16 9 ⁄ 28 32 0.029
Mean age (years) 49.6 ± 19 55.8 ± 12 NS
Gender (male) 255 ⁄ 573 44 13 ⁄ 29 44.8 NS
Fever 509 ⁄ 544 93.6 24 ⁄ 26 92 NS
Headache 455 ⁄ 528 86 17 ⁄ 23 73.9 NS
Nuchal rigidity 514 ⁄ 559 91.9 21 ⁄ 28 75 0.008
Vomiting 394 ⁄ 522 75.5 16 ⁄ 27 59 NS
Obtunded-comatoseb 427 ⁄ 568 75 25 ⁄ 28 89 NS
Hemiparesis 58 ⁄ 567 10 3 ⁄ 28 10.7 NS
Seizures 95 ⁄ 569 16.7 4 ⁄ 26 15 NS
Shock 43 ⁄ 573 7.5 4 ⁄ 29 13.8 NS
Escherichia coli aetiology 7 ⁄ 573 1 5 ⁄ 29 17 0.000
Listeria monocytogenes aetiology 28 ⁄ 573 4.9 5 ⁄ 29 17 0.017
Neisseria meningitidis aetiology 223 ⁄ 573 38.9 6 ⁄ 29 20.6 0.049
Streptococcus pneumoniae aetiology 178 ⁄ 573 31 8 ⁄ 29 27.5 NS
Unknown aetiology 72 ⁄ 573 12.5 1 ⁄ 29 3 NS
aChi-squared tests (or Fisher’s exact test when appropriate) were used for
categorical variables, and Student’s t-test was used for continuous variables.
bGlasgow coma scale <11.
NS, not significant (p >0.05).
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13 patients, hepatitis C virus-related in three
patients, and hepatitis B virus-related in one
patient. Causative microorganisms were: S. pneu-
moniae (n = 8; 27.5%); N. meningitidis (n = 6;
20.6%); Escherichia coli (n = 5; 17.2%); L. monocyt-
ogenes (n = 5; 17.2%); one (3.4%) each of Klebsiella
pneumoniae and Streptococcus agalactiae, Entero-
coccus faecalis and Streptococcus intermedius, and
one unknown case.
Upon admission, three patients were alert
(Glasgow Coma Scale (GCS) 12–15), 18 were
obtunded (GCS 9–11), and seven were comatose
with response to pain (GCS 4–8). The appearance
of the CSF was described as clear (n = 1, 3.7%),
opalescent (n = 3, 11%), purulent (n = 22, 81%)
and haemorrhagic (n = 1, 3.7%).
A primary focus of infection was identified in
ten patients. Among episodes of pneumococcal
meningitis, three cases were secondary to pneu-
monia, while among episodes of E. coli meningi-
tis, one case was concomitant with primary
peritonitis and two were associated with urinary
tract infection. The K. pneumoniae and S. interme-
dius episodes also had abdominal sources, while
the Ent. faecalis and S. agalactiae episodes were
related to urinary tract infection .
Penicillin susceptibility of isolates of S. pneu-
moniae causing meningitis was as follows:
susceptible (MIC £0.06 mg ⁄L, n = 5); partially
resistant (MIC 0.12–1 mg ⁄L, n = 1); and resistant
(MIC ‡2 mg ⁄L, n = 1).
The mean period of hospitalisation was
18.8 ± 14 days. Three patients relapsed, two with
E. coli meningitis and one with S. pneumoniae
meningitis. The first case involving E. coli (case 2,
Table 3) was a diabetic female, aged 36 years,
who relapsed 36 h after finishing a 22-day course
of ampicillin (MIC 2 mg ⁄L) for E. coli meningitis,
with satisfactory clinical course and a normal
control lumbar puncture. This patient died as a
result of septic shock. The relatively high ampi-
cillin MIC may explain the relapse, despite the
fact that ampicillin was standard therapy at this
time (1980). The other case involving E. coli
(case 6) was a female, aged 75 years, who was
treated with cefotaxime (12 g ⁄ 24 h, 30 kg body
weight), with good response to therapy, but who,
despite good CSF cefotaxime levels, relapsed
6 days after finishing a 15-day course for E. coli
meningitis of unknown source. Cefotaxime was
recommenced, resulting in an excellent clinical
response and sterile CSF. However, the patient
eventually died, on the seventh day of the second
course of cefotaxime, from unrelated causes. The
patient with pneumococcal meningitis who re-
lapsed had been treated with vancomycin and
dexamethasone as part of a study investigating
the use of vancomycin for pneumococcal menin-
gitis [16]; after relapse, this patient was cured
with high-dose cefotaxime. The overall mortality
rate was 48.2% (14 ⁄ 29 cases). Aetiology-related
mortality was as follows: E. coli, 5 ⁄ 5 cases;
Table 2. Laboratory data and out-
come of episodes in non-cirrhotic
and cirrhotic patientsa
Non-cirrhotic (n = 573) Cirrhotic (n = 29)
n ⁄ total % n ⁄ total % p
Positive blood cultures 268 ⁄ 573 46.8 18 ⁄ 29 62.1 NS
Median CSF white blood cell (IQR)b 1700 (74 999) 3150 (44 391) NS
Hypoglycorrhachia <40 mg ⁄dL 385 ⁄ 535 71.9 25 ⁄ 26 96.1 0.007
Proteinorhrachia >1 g ⁄L 427 ⁄ 573 74.5 24 ⁄ 29 82 NS
Proteinorrhachia >5 g ⁄L 160 ⁄ 573 27.9 10 ⁄ 29 34 NS
Positive CSF Gram’s stain 306 ⁄ 573 53.4 14 ⁄ 29 48.3 NS
Positive CSF culture 379 ⁄ 549 69 23 ⁄ 28 82.1 NS
Prothrombin time >1.3 min 138 ⁄ 484 28.5 13 ⁄ 21 61.9 0.001
Thrombopenia <100 · 109 ⁄L 74 ⁄ 536 13.8 8 ⁄ 24 33.3 0.015
Hyponatremia <135 mmol ⁄L 149 ⁄ 534 27.9 13 ⁄ 24 54 0.006
Relapse of fever 132 ⁄ 537 24.6 11 ⁄ 26 42 0.043
Renal function impairment 50 ⁄ 551 9.1 6 ⁄ 27 22.2 0.037
Liver function impairment 66 ⁄ 533 12.4 9 ⁄ 27 33.3 0.005
Mechanical ventilation 93 ⁄ 566 16.4 5 ⁄ 27 18.5 NS
Gastrointestinal bleeding 52 ⁄ 557 9.3 5 ⁄ 27 18.5 NS
Urinary tract infection 34 ⁄ 553 6.1 3 ⁄ 27 11.1 NS
Mean days to fever below 38C 2.1 ± 2.9 3.1 ± 4.5 NS
Mean days to improve mental status 1.6 ± 2.5 2.2 ± 3.8 NS
Relapse 6 ⁄ 481 1.2 3 ⁄ 17 17.6 0.002
Sequelaec 64 ⁄ 464 13.8 1 ⁄ 15 6.7 NS
Mortality 97 ⁄ 573 17 14 ⁄ 29 48.3 0.000
CSF, cerebrospinal fluid; IQR, inter-quartile range; NS, not significant (p >0.05).
aChi-squared tests (or Fisher’s exact test when appropriate) were used for categorical variables, and Student’s t-test
was used for continuous variables.
bMann–Whitney U-tests were used when the continuous variables were not normally distributed.
cIncludes seizures, hemiparesia, hearing loss, other cranial nerve palsy, disability and hydrocephalus.
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S. pneumoniae 4 ⁄ 8; other streptococci 3 ⁄ 3; K. pneu-
moniae, 1 ⁄ 1; and N. meningitidis, 1 ⁄ 6. Mortality
was attributed to sepsis in three (21%) cases, to
neurological complications in five (35.7%) cases,
and to late complications in the other six (42.8%)
cases. Neurological sequelae were present in one
(6.7%) of the surviving 15 cases. Three patients
with pneumococcal meningitis were treated with
dexamethasone as adjunctive therapy; one of
these patients died, after prolonged hospitalisa-
tion, from unrelated causes. A between-episodes
comparison of cirrhotic patients and the general
series was performed. Several significant differ-
ences are summarised in Tables 1 and 2, along
with other important characteristics.
In the multivariate analysis, Listeria aetiology
(OR 5.7; 95% CI 1.7–19.1), E. coli aetiology (OR
7.7; 95% CI 1.7–34.4), relapse of fever (OR 2.5;
95% CI 1.0–6.3) and mortality (OR 2.8; 95% CI
1.0–8.0) were associated significantly with a cir-
rhotic status. There was also a relationship
between the Child–Pugh classification and aetiol-
ogy. Less severe cases (Child–Pugh A and B)
presented with classic meningeal pathogens
(pneumococci or meningococci) or L. monocyto-
genes, while Child–Pugh C patients presented
with a higher frequency of infection caused by
Gram-negative bacilli. In summary, Child–Pug-
h A patients comprised three cases caused by
N. meningitidis, three by L. monocytogenes, three by
S. pneumoniae and one by S. intermedius; Child–
Pugh B patients comprised two cases caused by
N. meningitidis, two by L. monocytogenes, one by
S. pneumoniae, one by Ent. faecalis and one of
unknown origin; and Child–Pugh C patients
comprised five cases caused by E. coli, two cases
by S. pneumoniae, one by K. pneumoniae and one
by S. agalactiae.
DISCUSSION
According to the results of this study, bacterial
meningitis in cirrhotic patients is associated with
high mortality and a large number of complica-
tions. This is congruent with a study conducted in
Denmark [8], in which an incidence rate of
bacterial meningitis of 54.4 ⁄ 100 000, with a case
fatality rate of 53.1%, was observed in a nation-
wide cohort of 22 743 patients with liver cirrhosis.
As might be expected, the patients in the present
study showed significant differences in terms of
the presence of thrombopenia and hyponatremia
and the prothrombin time when compared to
non-cirrhotic patients, i.e., a picture of the classic
cirrhotic patient, who is a more vulnerable host
[17]. However, despite this impaired haemostatic
situation, there were no lumbar puncture-related
complications.
Another feature of the patients in the present
study was the absence of several clinical charac-
teristics that are usually considered to be impor-
tant when suspecting bacterial meningitis,
especially nuchal rigidity (p 0.008). Headache
and vomiting were also more frequently absent
among cirrhotic patients, although these were not
significant differences. However, these differ-
ences and the greater frequency of coma might
contribute to an erroneous diagnosis of hepatic
encephalopathy. Pauwels et al. [9] also suggested
that the absence of nuchal rigidity in some
patients might contribute to a delay in diagnosis
and a poor prognosis. Indeed, another significant
Table 3. Description of cirrhotic patients with meningitis who died or relapsed
Case Gender Age Year Underlying condition Child–Pugh Aetiology Focus Therapy Antibiotic MIC Outcome
1 F 59 1980 C Neiserria meningitidis PEN Death
2 F 36 1980 DM C Escherichia coli __ AMP 2 Relapse, CHL, death
3 F 53 1980 C E. coli Abdominal AMP + TOB AMP, CHL, death
4 F 58 1981 DM C E. coli PNA CHL + AG LP on fifth day, AMP, death
5 F 68 1983 DM C E. coli PNA CTX Death
6 F 75 1984 C E. coli __ CTX 0.25 Relapse, CTX, death
7 F 55 1986 DM C Klebsiella pneumoniae Abdominal CTX Death
8 M 51 1980 DM _ Streptococcus pneumoniae AMP 0.03 Death
9 M 60 1983 _ S. pneumoniae Pneumonia PEN 0.03 Death
10 F 55 1984 C S. pneumoniae None 0.03 Death
11 F 66 1988 C S. pneumoniae VAN 4 Relapse, CTX, cured
12 F 65 1995 Renal failure ⁄ steroids B Enterococcus faecalis Urinary AMP + CRO Death
13 F 69 1995 Neoplasm C Streptococcus agalactiae Urinary CRO 0.06 Death
14 M 59 1998 A Streptococcus intermedius Abdominal MER + AMP Death
15 M 59 1998 DM B S. pneumoniae CTX 2 Death
AMP, ampicillin; PEN, penicillin; CHL, chloramphenicol; CTX, cefotaxime; CRO, ceftriaxone; VAN, vancomycin; TOB, tobramycin; MER, meropenem; AG, aminoglycoside;
DM, diabetes mellitus; LP, lumbar puncture; PNA, acute pyelonephritis; M, male; F, female.
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difference was a longer disease course at the time
of diagnosis, which may be related to ambiguous
clinical signs and a low index of suspicion of
meningitis in patients who might be obtunded for
other reasons, e.g., encephalopathy. A high index
of suspicion is necessary to avoid this problem,
and this might also improve the diagnosis of other
infections, e.g., cryptococcal or tuberculous men-
ingitis.
A trend toward greater severity of disease upon
admission was also found, with a higher number
of patients being obtunded-comatose or with
shock and ⁄ or positive blood cultures. The number
of patients with positive CSF cultures and hypo-
glycorrhachia (p 0.007) was also higher. However,
perhaps the most important differences were with
respect to mortality (significant in the multivari-
ate analysis) and the possibility of complications.
Recurrence of fever, renal and liver function
impairment and relapse were all significant dif-
ferences, and there was also a trend towards a
higher frequency of gastrointestinal bleeding and
urinary tract infection, a longer period before
improvement of mental status, and a longer
period before the patient’s temperature dropped
to <38C. Such complications require additional
preventative efforts, as they are likely to play a
key role in the poor prognosis of these patients.
Vilstrup [3] also reported that infection-related
mortality was increased >20-fold in cirrhotic
patients.
According to the multivariate analysis, patho-
gens other than the classic meningeal pathogens
should be considered in these patients, especially
in Child–Pugh C patients, for whom meningitis
caused by Gram-negative bacilli is a real possi-
bility. Of the more classic pathogens, L. mono-
cytogenes was more prevalent than in other
immunocompromised patients, probably because
of the easy translocation of this organism into
the bloodstream from the gastrointestinal tract.
When considering empirical therapy for such
patients, a possible aetiology involving Gram-
negative bacilli and microorganisms that are
resistant to third-generation cephalosporins,
e.g., L. monocytogenes, should be considered,
and a combination of a third-generation cepha-
losporin and ampicillin is mandatory if a Gram’s
stain of the CSF shows no microorganisms and a
pneumococcal antigen test is negative. Also of
interest is the possible benefit of dexamethasone
in cirrhotic patients with pneumococcal menin-
gitis [18]. Consideration should also be given to
treating cirrhotic patients for a longer period to
reduce the possibility of relapse.
In conclusion, the present study revealed that
bacterial meningitis in cirrhotic patients is associ-
ated with a high mortality rate and a greater
number of complications. A high index of suspi-
cion is necessary, as several characteristic clinical
signs and symptoms of meningitis may be absent.
In addition to classic meningeal pathogens, other
microorganisms should also be considered when
prescribing empirical therapy for such patients,
with an additional effort being required to pre-
vent complications.
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